Search

BACKGROUND The amount of the macronutrients protein and carbohydrate (CHO) in a mixed meal is known to affect each other's digestion, absorption, and subsequent metabolism. While the effect of the amount of dietary protein and fat on the glycemic response is well studied, the ability of postprandial plasma amino acid patterns to predict the meal composition is unknown. OBJECTIVE To study the postprandial plasma amino acid patterns in relation to the protein, CHO, and fat content of different mixed meals and to investigate if these patterns can predict the macronutrient meal composition. DESIGN Ten older adults were given 9 meals with 3 different levels (low, medium, and high) of protein, CHO, and fat in different combinations, taking the medium content as that of a standardized western meal. We monitored the postprandial plasma response for amino acids, glucose, insulin, and triglycerides for 8 h and the areas under the curve (AUC) were subsequently calculated. Multiple regression analysis was performed to determine if amino acid patterns could predict the meal composition. RESULTS Increasing meal CHO content reduced the postprandial plasma response of several amino acids including all branched chain amino acids (BCAA) (leucine; q

Gut-related symptoms and an increase in markers of gut dysfunction have been observed in patients with chronic obstructive pulmonary disease (COPD). It remains unclear whether exercise, in relation to inducing hypoxia, plays a role in disturbances in protein digestion and amino acid absorption and whole body protein kinetics. Sixteen clinically stable patients with moderate-to-very severe COPD and 12 matched healthy subjects completed the study. Protein digestion and amino acid absorption, whole body protein kinetics were measured in the postabsorptive state via a continuous infusion of stable tracers in combination with orally administered stable tracer sips during 20 min of walking exercise and up to 4 h post exercise. In addition, concentrations of short-chain fatty acid (SCFA) and amino acids were measured. Patients with COPD completed one study day, walking at maximal speed, whereas healthy subjects completed two, one matched to the speed of a patient with COPD and one at maximal speed. The patients with COPD tolerated 20 min of vigorous intensity walking with an elevated heart rate (P < 0.0001) and substantial desaturation (P = 0.006). During exercise, we observed lower protein digestion (P = 0.04) and higher SCFA acetate (P = 0.04) and propionate (P = 0.02) concentrations on max speed study days, lower amino acid absorption (P = 0.004) in subjects with oxygen desaturation, and lower net protein breakdown (P = 0.03) and propionate concentrations (P = 0.04) in patients with COPD. During late recovery from exercise, amino acid absorption (P = 0.02) and net protein breakdown (P = 0.02) were lower in patients with COPD. Our data suggest that 20 min of walking exercise is sufficient to cause perturbations in gut function and whole body protein metabolism during and up to 4 h post exercise in older adults and in patients with COPD with exercise-induced hypoxia. NEW & NOTEWORTHY Gut function is disturbed in older adults with COPD. As exercise is the cornerstone of pulmonary rehabilitation in COPD, knowledge of the response of the gut to aerobic exercise is of importance.

The central position of methionine (Met) in protein metabolism indicates the importance of this essential amino acid for growth and maintenance of lean body mass. Therefore, Met might be a tempting candidate for supplementation. However, because Met is also the precursor of homocysteine (Hcy), a deficient intake of B vitamins or excessive intake of Met may result in hyperhomocysteinemia (HHcy), which is a risk factor for cardiovascular disease. This review discusses the evidence generated in preclinical and clinical studies on the importance and potentially harmful effects of Met supplementation and elaborates on potential clinical applications of supplemental Met with reference to clinical studies performed over the past 20 y. Recently acquired knowledge about the NOAEL (no observed adverse effect level) of 46.3 mg · kg-1 · d-1 and the LOAEL (lowest observed adverse effect level) of 91 mg · kg-1 · d-1 of supplemented Met will guide the design of future studies to further establish the role of Met as a potential (safe) candidate for nutritional supplementation in clinical applications.

Purpose: To determine whether adherence to a repeating 30-d non-linear diet intervention while participating in a supervised exercise program that includes resistance-exercise would promote weight and fat loss without weight loss plateau and whether alterations in carbohydrate and protein intake may influence results. Methods: Fifty sedentary and obese pre-menopausal females (35.2±7.6 years; 88.7±18 kg, 32.6±6 kg/m2, 42.5±4.2% fat) were randomly assigned to an exercise-only (EX) or EX plus diets containing higher proportions of carbohydrate or protein. Diets were hypoenergetic for 30-d (7-d at 1,200 kcals/d, 21-d at 1,500 kcal/d), more isoenergetic for 30-d (2,200 kcals/d), and repeated three times during a 24-wk intervention. Diets were either 45:30:24 (HCD) or 30:45:25 (HPD) carbohydate:protein:fat. All participants performed 30-min resistance exercise (3 d/wk) and a brisk walking program (3 d/wk). Data were analyzed by general linear model (GLM) statistics with repeated measures and presented as mean changes from baseline (mean [UL, LL]). Results: Participants experienced a significant and reduction in body weight (EX -2.24 [-6.5, 2.0], EX+HCD -6.99 [-9.4, -4.5], EX+HPD -4.49 [-7.1, -1.8] %), fat mass (EX -3.45 [-10.9, 4.03], EX+HCD -12.15 [-16.4, -7.9], EX+HPD -8.54 [-13.2, -3.9] %), and percent body fat (EX -1.30 [-5.6, 3.0], EX+HCD -5.91 [-8.3, -3.5], EX+HPD -4.31 [-7.0, -1.6] %) with those in the EX+HCD experiencing a more linear response. Participants in the EX and EX+HCD groups maintained fat-free mass to a better degree (EX -0.89 [-4.0, 2.2], EX+HCD -3.21 [-5.0, -1.2], EX+HPD -1.92 [-3.8, 0.002] %). Participants dieting generally experiencing greater benefit with some evidence that those in the EX+HPD experienced greater changes in blood lipids. Conclusion: A 30-day repeated non-linear diet can promote fat and weight loss without a plateau. Consuming a HPD may help maintain fat-free mass during weight loss and improve some markers of health compared to HCD interventions.

While commercial dietary weight-loss programs typically advise exercise, few provide actual programing. The goal of this study was to compare the Curves Complete 90-day Challenge (CC, n = 29), which incorporates exercising and diet, to programs advocating exercise (Weight Watchers Points Plus (WW, n = 29), Jenny Craig At Home (JC, n = 27), and Nutrisystem Advance Select (NS, n = 28)) or control (n = 20) on metabolic syndrome (MetS) and weight loss. We randomized 133 sedentary, overweight women (age, 47 ± 11 years; body mass, 86 ± 14 kg; body mass index, 35 ± 6 kg/m2) into respective treatment groups for 12 weeks. Data were analyzed using chi square and general linear models adjusted for age and respective baseline measures. Data are means ± SD or mean change ± 95% confidence intervals (CIs). We observed a significant trend for a reduction in energy intake for all treatment groups and significant weight loss for all groups except control: CC (−4.32 kg; 95% CI, −5.75, −2.88), WW (−4.31 kg; 95% CI, −5.82, −2.96), JC (−5.34 kg; 95% CI, −6.86, −3.90), NS (−5.03 kg; 95% CI, −6.49, −3.56), and control (0.16 kg, 95% CI, −1.56, 1.89). Reduced MetS prevalence was observed at follow-up for CC (35% vs. 14%, adjusted standardized residuals (adjres.) = 3.1), but not WW (31% vs. 28% adjres. = 0.5), JC (37% vs. 42%, adjres. = −0.7), NS (39% vs. 50% adjres. = −1.5), or control (45% vs. 55% adjres. = −1.7). While all groups improved relative fitness (mL·kg−1·min−1) because of weight loss, only the CC group improved absolute fitness (L/min). In conclusion, commercial programs offering concurrent diet and exercise programming appear to offer greater improvements in MetS prevalence and cardiovascular function after 12 weeks of intervention.

Acai (Euterpe oleracea Mart.) berries, characterized by high polyphenol concentrations (predominantly anthocyanins), have demonstrated anti-inflammatory and anti-diabetic activities. The study objective was to determine the modulation of lipid and glucose-metabolism, as well as oxidative stress and inflammation, by an acai-beverage (containing 1139 mg L−1 gallic acid equivalents of total polyphenolics) in 37 individuals with metabolic syndrome (BMI 33.5 ± 6.7 kg m−2) who were randomized to consume 325 mL twice per d of a placebo control or acai-beverage for 12 weeks. Anthropometric measurements, dietary intake, and blood and urine samples were collected at baseline and after 12 weeks of consumption. Two functional biomarkers, plasma level of interferon gamma (IFN-γ) and urinary level of 8-isoprostane, were significantly decreased after 12 weeks of acai consumption compared to the placebo control (p = 0.0141 and 0.0099, respectively). No significant modification of biomarkers for lipid- and glucose-metabolism was observed in this study. Findings from this small pilot study provide a weak indication that the selected dose of acai polyphenols may be beneficial in metabolic syndrome as only two biomarkers for inflammation and oxidative stress were improved over 12 weeks. Follow-up studies should be conducted with higher polyphenol-doses before drawing conclusions regarding the efficacy of acai polyphenols in metabolic syndrome.

Background: l-Methionine (Met) is an essential amino acid for humans and is important for protein synthesis and the formation of polyamines and is involved in the synthesis of many metabolites, including homocysteine. Free-Met supplements have been claimed to have multiple positive effects; however, it remains unclear what the exact tolerance level is. With aging, Met metabolism changes, and increased plasma homocysteine is more apparent. High plasma concentrations of homocysteine are assumed to be associated with a high risk of developing atherosclerosis.Objective: We estimated the no-observed-adverse-effect level (NOAEL) and the lowest-observed-adverse-effect level (LOAEL) of supplemented, oral, free Met in healthy older adults by examining the increase in plasma homocysteine as the primary determinant.Design: We provided capsules with free Met to 15 healthy older adult subjects for 4 wk at climbing dosages of, on average, 9.2, 22.5, 46.3 and 91 mg · kg body weight-1 · d-1 with washout periods of 2 wk between each intake. Before, at 2 and 4 wk during, and 2 wk after each dosage, we studied a complete panel of biochemical blood variables to detect possible intolerance to increased Met intake. Plasma homocysteine and body composition were measured, and tolerance, quality of life, and cognitive function were assessed via questionnaires.Results: Plasma homocysteine was elevated with the highest dose of supplemented Met. The estimated NOAEL of supplemented Met was set at 46.3 mg · kg body weight-1 · d-1, and the estimated LOAEL of supplemented Met was set at 91 mg · kg body weight-1 · d-1 (on the basis of the actual intakes) in subjects independent of sex. No signs of intolerance were observed via questionnaires or other blood variables at the LOAEL. There were no meaningful changes in body composition.Conclusions: On the basis of plasma homocysteine, the NOAEL of supplemented Met intake is 46.3 and the LOAEL is 91 mg · kg body weight-1 · d-1 in healthy older adults. Both the NOAEL and LOAEL are not associated with meaningful effects on health and wellbeing. This trial was registered at clinicaltrials.gov as NCT02566434.

Background The purpose of this study was to determine whether short-term supplementation of a powdered tart cherry supplement prior to and following stressful endurance exercise would affect markers of muscle damage, inflammation, oxidative stress, and/or muscle soreness. Methods 27 endurance-trained runners or triathlete (21.8 ± 3.9 years, 15.0 ± 6.0 % body fat, 67.4 ± 11.8 kg) men (n = 18) and women (n = 9) were matched based on average reported race pace, age, body mass, and fat free mass. Subjects were randomly assigned to ingest, in a double-blind manner, capsules containing 480 mg of a rice flour placebo (P, n = 16) or powdered tart cherries [CherryPURE®] (TC, n = 11). Subjects supplemented one time daily (480 mg/day) for 10-d, including race day, up to 48-hr post-run. Subjects completed a half-marathon run (21.1 km) under 2-hr (111.98 ± 11.9 min). Fasting blood samples and quadriceps muscle soreness ratings using an algometer with a graphic pain rating scale were taken pre-run, 60-min, 24 and 48-h post-run and analyzed by MANOVA with repeated measures. Results Subjects in the TC group averaged 13 % faster half-marathon race finish times (p = 0.001) and tended to have smaller deviations from predicted race pace (p = 0.091) compared to P. Attenuations in TC muscle catabolic markers were reported over time for creatinine (p = 0.047), urea/blood urea nitrogen (p = 0.048), total protein (p = 0.081), and cortisol (p = 0.016) compared to P. Despite lower antioxidant activity pre-run in TC compared to P, changes from pre-run levels revealed a linear increase in antioxidant activity at 24 and 48-h of recovery in TC that was statistically different (16–39 %) from P and pre-run levels. Inflammatory markers were 47 % lower in TC compared to P over time (p = 0.053) coupled with a significant difference between groups (p = 0.017). Soreness perception between the groups was different over time in the medial quadriceps (p = 0.035) with 34 % lower pre-run soreness in TC compared to P. Over the 48-h recovery period, P changes in medial quadriceps soreness from pre-run measures were smaller compared to TC. Conclusion Results revealed that short-term supplementation of Montmorency powdered tart cherries surrounding an endurance challenge attenuated markers of muscle catabolism, reduced immune and inflammatory stress, better maintained redox balance, and increased performance in aerobically trained individuals.

Methods Fifty sedentary, obese women (41.6 ± 12 yrs, 35.4 ± 8 kg/ m) were assigned to diet groups based on five obesityrelated genetic variants from four genes prominently associated with obesity (FABP2, PPARG, ADRB2, ADRB3). Participants were either truly matched (T) to their diet group based on genotype (n = 28) or falsely matched (F) based on genotype (n = 22). Prescribed diets consisted of 1,500 kcal/d and included carbohydrate:fat: protein percentages of 30:25:45 (H) or 20:35:45 (L). Participants performed a supervised circuit-style resistanceexercise program four days/week and a walking program consisting of 10,000 steps/day, three days/week. Body weight and duel energy X-ray absorptiometry (DXA) body composition measures were obtained at baseline, 4, 8, 12, 16, 20, and 24 weeks. Data were analyzed by MANOVA, with baseline body weight and body composition values used as covariates to normalize baseline differences between groups. Data are presented as changes from baseline at each time point, respectively. Results MANOVA revealed an overall Wilks’ Lamda time effect (p < 0.001) with no significant time by diet (p = 0.51), time × gene type (0.84), or time × diet × gene type (0.81) effects observed. Univariate analysis revealed that the exercise and diet interventions promoted significant reductions in weight (-5.36 ± 5.0 kg, p < 0.001), fat mass (-4.53 ± 3.6 kg, p < 0.001), and body fat (-2.88 ± 2.7 %, p < 0.001) with a trend toward a reduction in fat free mass (-0.65 ± 2.3 kg, p < 0.071). When baseline body weight and DXA body composition variables were used as covariates, Wilks’ Lambda time × diet (p = 0.098) tended to differ, a time × gene type interaction was observed (p = 0.011), while no differences were seen in time × diet × gene type (p = 0.18). Univariate analyses revealed some trends in time × diet changes in weight (H -2.03 ± 1.7, -3.13 ± 2.6, -4.17 ± 3.3, -4.62 ± 4.0, -4.75 ± 4.6, -4.41 ± 5.1; L -2.47 ± 1.8, -3.66 ± 2.4, -4.56 ± 3.1, -5.49 ± 3.9, -5.89 ± 4.5, -6.17 ± 4.8 kg, pq = 0.02), fat mass (H -1.53 ± 1.4, -2.67 ± 2.3, -3.63 ± 2.5, -3.73 ± 2.8, -4.14 ± 3.6, -3.95 ± 3.6; L -1.31 ± 1.6, -2.66 ± 2.2, -3.22 ± 2.5, -4.32 ± 2.9, -4.60 ± 3.0, -5.03 ± 3.7 kg, pq = 0.10), FFM (H -0.49 ± 1.2, -0.58 ± 1.5, -0.52 ± 1.8, -0.68 ± 2.4, -0.51 ± 2.2, -0.31 ± 2.3; L -0.95 ± 1.5, -0.73 ± 1.9, -1.20 ± 1.9, -0.86 ± 2.0, -1.03 ± 2.6, -0.94 ± 2.4 kg, p = 0.14), or body fat (H -0.50 ± 1.9, -1.51 ± 1.8, -2.32 ± 2.2, -2.22 ± 2.0, -2.68 ± 2.5, -2.65 ± 2.3; L -0.46 ± 1.5, -1.55 ± 2.1, -1.67 ± 2.4, -2.56 ± 2.5, -2.78 ± 2.7, -3.08 ± 3.0 %, pq = 0.13) generally in favor of the more carbohydrate restricted diet. Some trends were also seen in time × gene type changes in weight (T -2.06 ± 1.8, -2.91 ± 2.6, -3.99 ± 3.3, -4.83 ± 4.0, -5.07 ± 4.6, -5.15 ± 5.1; F -2.54 ± 1.7, -4.05 ± 2.2, -4.88 ± 2.9, -5.43 ± 3.8, -5.73 ± 4.6, -5.62 ± 5.0 kg, p = 0.20), Exercise & Sport Nutrition Lab, Texas A&M University, College Station, TX, USA Full list of author information is available at the end of the article Coletta et al. Journal of the International Society of Sports Nutrition 2015, 12(Suppl 1):P16 http://www.jissn.com/content/12/S1/P16

Background Consumption of tart cherry juice has been reported to increase endurance aerobic performance and attenuate perceptions of muscle soreness by reducing inflammation and oxidative stress that cause secondary muscle damage following endurance exercise. The purpose of this study was to determine if consumption of a powdered form of tart cherries derived from tart cherry skins (CherryPURE Freeze Dried Tart Cherry Powder) prior to and following strenuous endurance exercise increases performance while attenuating markers of inflammation and oxidative stress.

Background The purpose of this study was to examine whether short-term ingestion of a powdered tart cherry supplement prior to and following intense resistance-exercise attenuates muscle soreness and recovery strength loss, while reducing markers of muscle damage, inflammation, and oxidative stress. Methods Twenty-three healthy, resistance-trained men (20.9 ± 2.6 yr, 14.2 ± 5.4 % body fat, 63.9 ± 8.6 kg FFM) were matched based on relative maximal back squat strength, age, body weight, and fat free mass. Subjects were randomly assigned to ingest, in a double blind manner, capsules containing a placebo (P, n = 12) or powdered tart cherries [CherryPURE®] (TC, n = 11). Participants supplemented one time daily (480 mg/d) for 10-d including day of exercise up to 48-h post-exercise. Subjects performed ten sets of ten repetitions at 70 % of a 1-RM back squat exercise. Fasting blood samples, isokinetic MVCs, and quadriceps muscle soreness ratings were taken pre-lift, 60-min, 24-h, and 48-h post-lift and analyzed by MANOVA with repeated measures. Results Muscle soreness perception in the vastus medialis (¼) (p = 0.10) and the vastus lateralis (¼) (p = 0.024) was lower in TC over time compared to P. Compared to pre-lift, TC vastus medialis (¼) soreness was significantly attenuated up to 48-h post-lift with vastus lateralis (¼) soreness significantly lower at 24-h post-lift compared to P. TC changes in serum creatinine (p = 0.03, delta p = 0.024) and total protein (p = 0.018, delta p = 0.006) were lower over time and smaller from pre-lift levels over time compared to P Significant TC group reductions from pre-lift levels were found for AST and creatinine 48-h post-lift, bilirubin and ALT 60-min and 48-h post-lift. No significant supplementation effects were observed for serum inflammatory or anti-inflammatory markers. None of the free radical production, lipid peroxidation, or antioxidant capacity markers (NT, TBARS, TAS, SOD) demonstrated significant changes with supplementation. Changes in TC whole blood lymphocyte counts (p = 0.013) from pre-lift were greater compared to P, but TC lymphocyte counts returned to pre-lift values quicker than P. Conclusion Short-term supplementation of Montmorency powdered tart cherries surrounding a single bout of resistance exercise, appears to be an effective dietary supplement to attenuate muscle soreness, strength decrement during recovery, and markers of muscle catabolism in resistance trained individuals.

Diagnosing insulin resistance via an OGTT can be costly and impractical. However, this information can be useful in recommending proper diet for individuals interested in losing weight. This study ...

Our aim was to examine the acute (5 h) hemodynamic (HR & BP) and hematologic profiles for a (1) Placebo (PL), (2) Creatine (CR, 5 g), (3) Creatine Nitrate (CrN; 1 g CR; 0.5 N) and (4) CrN2X (2 g CR; 1.0 g N) formula administered in a randomized, double-blind manner with 7d of washout between treatments. Participants (N=13; 22 ± 2 y) presented for testing after abstaining from exercise and fasting for 8 h. Initial unsupplemented measures (Time 0) were assessed, followed by supplement ingestion and serial sampling (0.5, 1, 2, 3, 4, 5h). Variables included heart rate, blood pressure, liver (ALP, AST, ALT), kidney (creatinine, BUN), and muscle (CK, LDH) enzymes, glucose and blood lipids. Analyses included GLM and LSD post-hoc procedures. Significant within group perturbations were noted for LDL-C (CR, PL), HDL-C (CrN, CrN2X), triglycerides (CrN2X, PL), glucose (CrN2X), creatinine (all), CK (CrN2X, PL), BUN (all), ALT (PL) over the 5h study period (all, P < 0.03). Corresponding between group differences (all, ...

We examined 28d of randomly assigned of (1) Placebo (PL), (2) Creatine (CR, 3 g), (3) Creatine Nitrate (CrN; 1 g CR; 0.5 N) and (4) CrN2X (2 g CR; 1.0 g N) on exercise performance and body composition. Participants (N=48; 21 ±3 y) presented for fasting (12h) testing after abstaining from exercise and alcohol for 48h. Performance (reps at 70% of bench press 1 RM [BP] and repeated sprints on cycle ergometer) was measured at 0 & 4 wks. Body composition (DXA) was measured at 0, 1, & 4 wks. We used GLM to examine mean change (95% CI) from baseline. While all three treatment groups significantly increased BP repetition at 4 wks, total BP lifting volume was greater at 4 wks for CrN2X (294.6 lbs; 95% CI, 196, 393) vs CrN (164.2 lbs; 95% CI, 25, 304) and PL (187.1 lbs;95% CI, 37, 336, both p=0.02). No treatment effects were observed for cycle ergometry testing (peak or mean power, fatigue slope, and total work). While no difference in fat mass were observed for any treatment group, CrN2X did augment lean mass (1.2...

Resistin and visfatin are secreted by adipose tissue and potential regulators of inflammation and insulin sensitivity. This study examined the effects of exercise and diet-induced weight loss on resistin, visfatin and other adiposity and inflammatory markers. 26 sedentary obese women were randomly assigned into a control (C) or an exercise (E) group that involved circuit resistance-exercise (4 d/wk) with walking (10,000 steps/d, 3 d/wk) while consuming 1,200 kcal/day for 1-wk and 1,500 kcal/d diet for 11 wks consisting of 45:30 % PRO:CHO. Baseline and post-training DEXA body composition and fasting blood samples were obtained and analyzed by MANOVA and Pearson correlation analysis. Data are presented as mean±SD changes from baseline. Participants in the E group lost more weight (E: -13.0±8.9; C: -1.4±3.1 lbs, p=0.001) and fat (E: -5.1±4.5; C:-0.4±1.5 kg, p=0.001). Significant differences were seen between groups in leptin (E: -19.8±21.9; C: 4.5±16 ng/ml, p=0.003) while visfatin (E: -0.09±15.4; C: 89.3±177...

This study examined whether genetic profile influences response to a diet and exercise intervention. 53 sedentary women (38±12 yrs, 80.8±13.9 kg) were randomized to a control group (C) or exercise + diet groups. Those in exercise groups performed circuit resistance-exercise (4 d/wk) and walked (10,000 steps, 3 d/wk). Diets were 1,500 kcal/d with 20:35:45 (CI), 30:25:45 (CII) or 55:30:15 (AHA) percentages of CHO:FAT: PRO. Buccal cheek swabs were obtained at baseline and analyzed for FABP2, PPARG, ADRB-79, ADRB3, and ADRB-46 genes to determine true (T) or false (F) genetic matches to higher CHO or CHO restricted diets. Body weight and DEXA body composition measurements were obtained at 0, 4, 8, 12, 16, 20, and 24 wks. Data were analyzed by MANOVA and are presented as changes from baseline. An overall Wilk's Lambda time x diet (p=0.085) and time x diet x genotype (p=0.102) trend was observed. Univariate analysis revealed significant interaction trends in fat mass (C: 0.39±1.26; CI: T -6.16±5.04, F -1.58±2.22...

Pre-workout supplements can increase energy availability and/or exercise capacity. We examined the effects of ingesting a pre-workout supplement with and without synephrine for 8w in 78 healthy, resistance-trained men (22 ± 3 y). Subjects were randomly assigned to treatments of: (1) a dextrose flavored placebo (PLA); (2) a supplement containing 3.0 g beta alanine, 2 g creatine nitrate, 2 g arginine AKG, 300 mg of N-acetyl tyrosine, 270 mg caffeine, 15 mg of Mucuna pruriens (PWS) or (3) PWS + 20 mg of synephrine (PWS+S). Primary outcomes: Cognitive function (CF) via a Stroop test. Secondary outcome: Rate of readiness via a visual analogue scale (RTP-VAS). Measures were assessed at 0, 4 & 8 w. We used GLM statistical analyses covaried for age and respective baseline measures to determine mean (95% CI) change from baseline. We observed a significant increase in CF for the word test at 4 wks for PWS+S (5.64 count; 2.09, 9.19) and PLA (3.9 count; 0.39, 7.45), and 8 wks for PWS (7.55 count; 4.14, 10.97), PWS+S ...

This study examined whether genotype of some obesity-related genes (FABP2, PPARG, ADRB2-79, ADRB2-46, ADRB3) influences success to different diets while participating in an exercise program. 40 sed...

Background Consumption of tart cherry juice has been reported to effectively reduce inflammation, muscle damage, and muscle soreness following bouts of exercise. The purpose of this study was to determine if consumption of a powdered form of tart cherries derived from tart cherry skins prior to and following intense endurance exercise promotes similar positive results as seen with tart cherry juice consumption.

Background A number of nutritional strategies have been developed to optimize nutrient delivery prior to exercise. As a result, a number of pre-workout supplements have been developed to increase energy availability, promote vasodilation, and/ or positively affect exercise capacity. The purpose of this study was to examine the acute effects of ingesting a preworkout dietary supplement with and without synephrine on energy metabolism and cardiovascular hemodynamics. Methods

Background Consumption of tart cherry juice has been reported to effectively reduce inflammation, muscle damage, and muscle soreness following bouts of exercise. The purpose of this study was to determine if consumption of a powdered form of tart cherries derived from tart cherry skins prior to and following intense resistance exercise promotes similar positive results as seen with tart cherry juice consumption.

Background A number of nutritional strategies have been developed to optimize nutrient delivery prior to exercise. As a result, a number of pre-workout supplements have been developed to increase energy availability, promote vasodilation, and/ or positively affect exercise capacity. The purpose of this study was to examine the acute effects of ingesting a preworkout dietary supplement with and without synephrine on cognitive function, perceptions of readiness to perform, and exercise performance.

The OGTT is a gold standard in assessing carbohydrate intolerance (CI) and insulin resistance. However, the test is costly and time consuming. This study examined whether a CI survey could predict response to an OGTT. 108 women (31.6±13 yr, 34.7±7% body fat, 25.3±4 kg/m2) donated fasting blood samples, completed a CI inventory, had body composition and health measures determined, and underwent a 75 g OGTT in which glucose samples and perceptions of CI symptoms were obtained at 0, 30, 60, 90, and 120 minutes. Pearson product correlations were performed to determine which factors correlated with OGTT glucose AUC. Results revealed significant correlations (p

The purpose of this study was to examine the relationship of responses to a carbohydrate intolerance (CI) questionnaire to body composition and markers of health. 108 women (31.6±13 yrs, 34.7±7% bo...

The OGTT is a gold standard in assessing carbohydrate intolerance (CI) and insulin resistance. However, the test is costly and time consuming. This study examined whether responses to a carbohydrat...

The fasting homeostatic model assessment (HOMA) is a gold standard in assessing insulin resistance. However, the test is costly and time consuming. This study examined whether responses to a carbohydrate intolerance survey (CI) correlate to HOMA, an OGTT, body composition and/or markers of health. 108 women (31.6±13 yrs, 34.7±7% body fat, 25.3±4 kg/m2) donated fasting blood samples, completed a CI inventory, had body composition and health measures determined, and underwent a 75g, 2-hr OGTT. Pearson product correlations were performed to determine which factors correlated with HOMA. Results revealed significant correlations (p

The purpose of this study was to determine if different types of exercise and diet interventions promote greater changes in visceral adipose tissue (VAT). 54 sedentary women (34±8 yrs, BMI 35±6) we...

The purpose of this study was to determine if different diet and exercise programs differentially affect android and/or gynoid body composition changes in sedentary women. 54 sedentary women (34±8 ...

The purpose of this study was to determine if different diet and exercise programs differentially affect android and/or gynoid body composition changes in sedentary women. 127 sedentary women (46±12 yr, 45.5±5% body fat, BMI 35.1±5) were randomized to participate in a control group (C) or the Curves Complete® program with online support (CC), Weight Watchers® Points Plus (WW), Jenny Craig® (JC), or Nutrisystem® Advance Select™ (NS) weight loss programs for 12-wks. DEXA body composition with android (A) and gynoid (G) measurements were obtained. MANOVA revealed a significant time (p

The purpose of this study was to determine if different types of exercise and diet interventions promote greater changes in visceral adipose tissue (VAT). 127 sedentary women (46±12 yr, 45.5±5% body fat, 35.1±5 kg/m2) were randomized to participate in a control group (C) or the Curves Complete® program with online support (CC), Weight Watchers® Points Plus (WW), Jenny Craig® (JC), or Nutrisystem® Advance Select™ (NS) weight loss programs for 12-wks. DEXA body composition with VAT determination was obtained at 0 & 12 wks. MANOVA revealed significant (p=

Background Obesity is associated with many negative health outcomes. Diet and exercise has been shown to reduce obesity and various other factors linked to poor health. One of the major concerns is the expense of diet and exercise programs. This study compared the cost effectiveness of four popular weight loss programs and controls in terms of weight loss success and outcomes. Methods

Effects of immediate and delayed nutrient timing following resistance exercise on changes in mixed muscle fractional synthesis rate (FSR) in post-menopausal women participating in a weight loss program M Byrd, S Simbo, YP Jung, B Sanchez, M Cho, CW Lee, B Lockard, C Baetge, K Levers, E Galvan, A Jagim, JM Oliver, R Dalton, B Bessire, K Horrell, T Leopold, M Koozehchian, D Khanna, K Shimkus, W Gapinsky, M Perez, J Hart, S Riechman, J Fluckey, M Greenwood, C Rasmussen, R Kreider

21 sedentary women (59.8±5 yr, 43.7±3% body fat, 31.0±3 kg/m2) followed Curves Complete® energy-restricted diet (30% C, 45% P, and 25% F) while participating in a circuit resistance-training (3 d/w...